A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease (GREEN MEMORY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04520412

Recruitment Status : Suspended (The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.)

First Posted : August 20, 2020

Last Update Posted : November 23, 2022

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Suspended
Estimated Primary Completion Date :	December 2025
Estimated Study Completion Date :	October 2026

To Top